Heat Shock Proteins in Cancers
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Tumor Microenvironment".
Deadline for manuscript submissions: 15 December 2024 | Viewed by 1016
Special Issue Editors
Interests: thermoregulation; adaptive physiology; physical activity; rehabilitation; sports medicine; aging
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Heat shock proteins (HSPs), molecular chaperone proteins, are known to be one of the main proteins that play a role in maintaining cell homeostasis. They are involved in the process of protein folding and its maturation; they also play a role in cell proliferation and differentiation, as well as in the process of carcinogenesis. The increased expression of HSPs that occurs during the neoplastic process favors the creation of an environment suitable for the development of a neoplastic tumor, during which cellular homeostasis is dysregulated. HSPs are of multidirectional importance in the development of cancer, including by increasing their proliferation, promoting the avoidance of antigrowth signals and escaping from cell death, inhibiting cell aging, increasing angiogenesis and metastasis, or avoiding responses from the immune system.
Due to their properties, HSPs are an alternative to anticancer therapy, e.g., when tumor cells become resistant to currently available treatment. The inhibition of HSPs in cancer therapy may provide promising results, among others, by eliminating proteins responsible for tumor growth. Tumor-specific HSPs may be good prognostic markers of an organism's response to treatment.
Understanding the exact mechanisms of HSP (intracellular and extracellular) action is important due to the development of alternative, but also more precise methods of treatment of various types of cancers of clinical significance.
Prof. Dr. Anna Lubkowska
Dr. Weronika Ratajczak
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- heat shock proteins
- extracellular HSPs
- intracellular HSPs
- cancer
- cancer therapy
- biomarkers
- molecular targets
- cancer biology
- cancer pharmacology
